Dr. Silverman studies the fundamental aspects of early-life commensal microbes that influence immune system development and function. He discovered that the MHC-II E molecule prevents type 1 diabetes by shaping the intestinal microbiota early in life.
If you're eager to learn and a creator of change - which pretty much covers everyone here at the Research Institute - then you'll want to know about what's happening at the Pediatric Academic Societies Annual Meeting (PAS), the largest international meeting focusing on research in child health.
The Silverman Lab investigates early-life modifiable factors influencing the development and function of the immune system and harnesses these factors to prevent autoimmune diabetes (T1D). The lab discovered that the major histocompatibility complex class II E molecule prevents T1D by shaping the intestinal microbiota early in life.
